A Joint Venture for Defeating Infectious Threats Post-Transplantation: Pathologists and Microbiologists Together
27 June, 2024 3:00 p.m. to 4:00 p.m. EDT
Heart and lung transplant recipients are highly susceptible to conventional and opportunistic infections, which represent a major cause of morbidity, graft dysfunction and mortality. Transplant providers must stay abreast of the intricate details of infectious disease processes and associated diagnostic tools to adequately diagnose and manage transplant-related infections. Frequent review of current practices in transplantation and infectious diseases is essential to keep up with and adhere to the latest treatment strategies.
This session will examine the risk factors relevant to heart and lung transplant recipients, and the syndromes associated with them, such as respiratory failure, sepsis, and CNS infection. It will provide practitioners with outlooks that are current and unique to diagnose and provide care to transplant recipients infected with illnesses. Newer and current diagnostic approaches to identify specific pathogens will be discussed in detail.
Moderators
Oksana Volod, MD
Christine Koval, MD
Presentations
Objectives
- Discuss correct specimen collection and processing.
- Discuss current and new methods (culture, nucleic acid - based methods (NAAT), non-nucleic acid-based methods (chromatographic, mass spectroscopy
- Discuss the methods for tissue handling and processing.
Presented by Margie Morgan, PhD and David Hwang, MD, PhD
Objectives
- Discuss pretransplant recipient associated (ECMO, VAD) infectious complications
- Discuss surgical complications related infections
- Discuss donor derived infections (CMV, EBV, Toxoplasma)
Presented by Sharron Liang and Tina Marinelli, FRACP
Objectives
- Discuss reactivation of latent infection
- Discuss opportunistic infections
- Discuss community acquired infections
- Healthcare associated infections
Presented by Justin Burk, DO and Chien-Yu Lin, MD, PhD
With all Speakers
